Results 1 to 10 of about 208,496 (229)

N-acetylation of 2-aminobenzothiazoles with Acetic Acid for Evaluation of Antifungal Activity and In Silico Analysis

open access: yesJournal of Molecular Docking, 2021
Acetamides (S30A1 and S30) were synthesized from benzo[d]thiazol-2-amine and 6-nitrobenzo[d]thiazol-2-amine by direct use of acetic acid instead of acetylating agents.
Sukumar Bepary   +4 more
doaj   +1 more source

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking

open access: yesJournal of Molecular Docking, 2021
SARS-CoV-2, a new type of Coronavirus, has affected more millions of people worldwide. From the spread of this infection, many studies related to this virus and drug designing for the treatment have been started. Most of the studies target the SARS-CoV-2
Achal Mishra, Radhika Waghela
doaj   +1 more source

Comparative In-Silico Molecular Docking of Silymarin for SARS-CoV-2 Receptor

open access: yesJournal of Molecular Docking, 2022
COVID-19 pandemic has spread across the world in over 185 countries, with millions of infections and hundreds of thousands of deaths. The current pandemic has made the situation worse, forcing the development of better treatment.
Michael Antony Samy Amutha Gnana Arasi   +2 more
doaj   +1 more source

High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. [PDF]

open access: yesPLoS Computational Biology, 2009
Virtual compound screening using molecular docking is widely used in the discovery of new lead compounds for drug design. However, this method is not completely reliable and therefore unsatisfactory.
Noriaki Okimoto   +8 more
doaj   +1 more source

Computational strategies for PROTAC drug discovery

open access: yesActa Materia Medica, 2023
Proteolysis-targeting chimeras (PROTACs), a novel targeted protein degradation technology for potential clinical drug discovery, is composed of a protein-targeting ligand covalently linked to an E3 ligase ligand.
Jia Wu, Wanhe Wang, Chung-Hang Leung
doaj   +1 more source

Molecular Docking Study of Caffeic Acid as Acetylcholinesterase Inhibitor

open access: yesJournal of Food and Pharmaceutical Sciences, 2023
Acetylcholinesterase (AChE) receptor is a receptor that has been widely used as a potential drug target for Alzheimer's disease. Caffeic acid is a phenolic compound that had been experimentally proven to be an inhibitor of AChE.
Stephanus Satria Wira Waskitha   +2 more
doaj   +1 more source

Molecular Docking Studies of Spirostans as MAPK14 (P38α) Inhibitors and Their Potential Use against Cancer

open access: yesJournal of Molecular Docking, 2021
Spirostans (SPs) are chemical products widely distributed in the plant kingdom; currently, they are studied by their medical applications. Cancer has a high incidence in humans; it reaches second place worldwide deaths.
Guiee Niza Lopez-Castillo   +4 more
doaj   +1 more source

Receptor–ligand molecular docking [PDF]

open access: yesBiophysical Reviews, 2013
Docking methodology aims to predict the experimental binding modes and affinities of small molecules within the binding site of particular receptor targets and is currently used as a standard computational tool in drug design for lead compound optimisation and in virtual screening studies to find novel biologically active molecules.
Isabella A, Guedes   +2 more
openaire   +2 more sources

Cover, Content, and Editorial Note from J Mol Docking Vol. 1 No. 1 June 2021

open access: yesJournal of Molecular Docking, 2021
Assalamu’alaikum Wr. Wb. Alhamdulillahirabbil ‘alamin. After a long wait for almost 1 year from the first planned, finally, the new scientific journal of the Department of Pharmacy Universitas Muhammadiyah Palangkaraya can be published.
Chief Editor of J Mol Docking
doaj   +1 more source

A real-time proximity querying algorithm for haptic-based molecular docking [PDF]

open access: yes, 2014
Intermolecular binding underlies every metabolic and regulatory processes of the cell, and the therapeutic and pharmacological properties of drugs.
Bayazit   +44 more
core   +1 more source

Home - About - Disclaimer - Privacy